Impaired transporter associated with antigen processing (TAP) function attributable to a single amino acid alteration in the peptide TAP subunit TAP1.
J Immunol
2003
170
2
941-6
Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery.
Curr Drug Targets Infect Disord
2003
3
3
263-71
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial.
Hum Gene Ther
2003
14
14
1347-60
Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
Cancer Res
2003
63
14
4107-11
Comparison of virus production in chicken embryo fibroblasts infected with the WR, IHD-J and MVA strains of vaccinia virus: IHD-J is most efficient in trans-Golgi network wrapping and extracellular enveloped virus release.
J Gen Virol
2003
84
Pt 6
1383-92
Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.
J Virol
2003
77
8
4635-45
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice.
J Immunol
2003
170
1
270-8
Analysis of nuclear targeting activities of transport signals in the human immunodeficiency virus Rev protein.
Exp Cell Res
2003
291
2
484-501
Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.
J Virol
2003
77
24
13348-60